How much do we know about the risks?
CJC-1295 side effects have not been counted well
Safety studies in people were small and brief. Growth hormone can cause some of these harms, but no sound study tells you the chance of harm.
No large study has measured these risks
The safety record for CJC-1295 is short. Early studies gave healthy adults the drug and watched growth hormone and IGF-1, a growth-related blood reading, change [12]. They were too small and brief to give sound rates of harm. No drug agency has approved CJC-1295 for use in people [4].
That missing work is the main fact on this page. Some CJC-1295 worries come from the known effects of growth hormone. The FDA raised others. You don't get a measured chance of harm from any large study.
I'd want that limit clear before reading a list of possible side effects. A possible harm isn't a counted risk. Yet the lack of a count doesn't make the drug safe. Both facts belong in your decision.
Growth hormone can bring swelling and sugar trouble
CJC-1295 keeps growth hormone and IGF-1, a growth signal in blood, high for a time. Growth hormone can leave extra salt and water in your body [12]. Swelling may follow. Insulin may also control your blood sugar less well.
No large CJC-1295 study counted those harms. Doctors must instead use what they know about growth hormone and similar drugs. A separate study found that related growth drugs changed how the body used food and protein [10]. It didn't count harm from this drug or give you a personal risk number.
Which CJC-1295 side effects concern doctors?
Growth hormone may stop your kidneys from letting enough salt and water leave. Swelling may follow, and insulin may control your blood sugar less well [12]. Certain cancers appeared a little more often among people with higher IGF-1, a growth-related blood reading, but that doesn't prove this drug caused cancer [12]. The FDA gave another warning: your immune system may attack the drug as foreign [12].
A lasting IGF-1 rise raises a cancer question
People with higher IGF-1 in blood have had slightly more of certain cancers [12]. It is a growth-related reading. You can't use that link to blame IGF-1 or CJC-1295 for those cancers. Still, IGF-1 staying high calls for caution.
One CJC-1295 shot raised IGF-1 1.5- to 3-fold for nine to eleven days [1]. After several shots, IGF-1 remained above the starting point through 28 days. No study linked the drug to a cancer case. The honest answer is concern, not proof.
The FDA warned that the immune system may reject the drug
No major drug agency has approved CJC-1295 for people [4]. In 2024, FDA advisers warned that your immune system might attack the drug as foreign. That could cause harm or make the drug stop working, but the review couldn't say how often [12]. You have a warning, not a measured rate.
The company testing long-acting CJC-1295 stopped its work. A Phase 2 study—an early test in people meant to look for benefit and watch safety—tested people with HIV-associated deep belly fat and did not move ahead [12]. One person died while the work was under way. The public report gives you no cause, so you can't know whether CJC-1295 played a part [12].
Tested athletes face a separate, clear rule. CJC-1295 is barred at all times under world sports rules [4]. The ban applies even when the drug has no effect. A positive test can still bring you a penalty.
The label may not match what is in a vial
The vial itself brings another risk. Sellers of lab chemicals don't prove each vial the way an approved drug maker must. In 2010, a lab identified CJC-1295 in a seized vial whose contents were unknown [6]. You can't use that case to tell what another vial holds.
Here is the practical concern. CJC-1295 isn't sold as approved medicine. You may get the wrong drug, the wrong amount, or germs in a vial. Its printed label can't settle those questions for you.
Has CJC-1295 been shown to be safe?
No. CJC-1295 isn't approved medicine, and no large study watched people for long-term harm [12]. Growth hormone may leave you swollen and may upset your blood sugar. High IGF-1, a growth-related blood reading, raises a cancer question, while the FDA warned that your immune system may attack the drug as foreign [12].
Are CJC-1295 peptide drugs safe?
No research has proved these peptide drugs safe. A peptide is a few linked protein parts. CJC-1295 isn't approved and has no long safety study in people [12]. Worries include swelling, blood-sugar changes, a lasting growth rise, the body rejecting the drug, and unknown vial contents [6].
Did CJC-1295 change testosterone?
CJC-1295 acts by raising growth hormone, rather than through the glands that make testosterone [12]. You won't find a direct testosterone rise or fall in a CJC-1295 study. Work on IGF-1, a growth-related blood reading, doesn't answer the question. The facts point neither way for you.
What happened after people took CJC-1295?
After one shot, studies found growth hormone and IGF-1, a growth-related blood reading, stayed higher for days [1][3]. People still had the usual rises and falls in growth hormone. Neither result tells you how their bodies felt. Drug agencies haven't approved CJC-1295 for use in people [4].